Cross Country Healthcare, Inc. Aktie News

BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the “Company” and “Cross Country”) (Nasdaq: CCRN) today announced that John A. Martins, the Company's President and Chief Executive Officer, has separated from the Company and ceased to serve as a member of its Board of Directors (the “Board”), effective as of December 14, 2025. The Board appointed Kevin C. Clark, the Company's ...

Cross Country Healthcare saw its merger with Aya Healthcare collapse after the government shutdown pushed back the HSR waiting period expiration date. CCRN will receive a $20 million termination fee from Aya, adding to an already formidable cash position. Management has announced that it will immediately undergo up to $40 million in share buybacks, capitalizing on a low stock price.

BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the “Company” and “Cross Country Healthcare”) (Nasdaq: CCRN) today announced the termination of its Agreement and Plan of Merger (the “Merger Agreement” and, the transactions contemplated thereby, the “Aya Merger”) with Aya Holdings II Inc., a Delaware corporation (“Parent”), Spark Merger Sub One Inc., a Delaware corporation and...

BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the Company) (Nasdaq: CCRN) today announced financial results for its third quarter ended September 30, 2025. Selected Financial Information:     Variance Variance     Q3 2025 vs Q3 2025 vs Dollars are in thousands, except per share amounts Q3 2025 Q3 2024 Q2 2025 Revenue $ 250,052     (21 )%   (9 )% Gross profit margin*   20.4 ...

BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country announced today that its marketing team has been named the No. 1 Marketing Team in the Nation by the 2025 OnCon Icon Awards.

Cross Country Healthcare (CCRN 2.02%), a major provider of healthcare staffing solutions, reported its second quarter results on August 6, 2025. The company reported a substantial miss on both GAAP revenue and non-GAAP EPS.

BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the Company) (Nasdaq: CCRN) today announced financial results for its second quarter ended June 30, 2025. Selected Financial Information:     Variance Variance     Q2 2025 vs Q2 2025 vs Dollars are in thousands, except per share amounts Q2 2025 Q2 2024 Q1 2025 Revenue $ 274,072     (19 )%   (7 )% Gross profit margin*   20.4 %   ...

I previously rated CCRN a sell, arguing that the FTC could block the merger because of concerns about competition in healthcare markets. The stock price now offers a 45% upside if the Aya merger closes, with the market pricing in only a 22% chance of the deal completing. Management continues to guide toward the deal completing in the second half of 2025.